These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. Zhang J; Salamonsen LA J Clin Endocrinol Metab; 2002 May; 87(5):2346-51. PubMed ID: 11994386 [TBL] [Abstract][Full Text] [Related]
9. Production of interleukin-1alpha by human endometrial stromal cells is triggered during menses and dysfunctional bleeding and is induced in culture by epithelial interleukin-1alpha released upon ovarian steroids withdrawal. Pretto CM; Gaide Chevronnay HP; Cornet PB; Galant C; Delvaux D; Courtoy PJ; Marbaix E; Henriet P J Clin Endocrinol Metab; 2008 Oct; 93(10):4126-34. PubMed ID: 18628526 [TBL] [Abstract][Full Text] [Related]
10. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Freitas S; Meduri G; Le Nestour E; Bausero P; Perrot-Applanat M Biol Reprod; 1999 Oct; 61(4):1070-82. PubMed ID: 10491646 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Lockwood CJ; Krikun G; Hausknecht VA; Papp C; Schatz F Endocrinology; 1998 Nov; 139(11):4607-13. PubMed ID: 9794472 [TBL] [Abstract][Full Text] [Related]
12. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. Irwin JC; Kirk D; Gwatkin RB; Navre M; Cannon P; Giudice LC J Clin Invest; 1996 Jan; 97(2):438-47. PubMed ID: 8567965 [TBL] [Abstract][Full Text] [Related]
13. Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. Cornet PB; Galant C; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P J Clin Endocrinol Metab; 2005 Feb; 90(2):1001-11. PubMed ID: 15536155 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831 [TBL] [Abstract][Full Text] [Related]
15. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo. Vassilev V; Pretto CM; Cornet PB; Delvaux D; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P J Clin Endocrinol Metab; 2005 Oct; 90(10):5848-57. PubMed ID: 16046583 [TBL] [Abstract][Full Text] [Related]
16. Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell. Wahab M; Taylor AH; Pringle JH; Thompson J; Al-Azzawi F Mol Hum Reprod; 2006 Mar; 12(3):157-67. PubMed ID: 16556677 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. Rawdanowicz TJ; Hampton AL; Nagase H; Woolley DE; Salamonsen LA J Clin Endocrinol Metab; 1994 Aug; 79(2):530-6. PubMed ID: 8045973 [TBL] [Abstract][Full Text] [Related]
18. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1. Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578 [TBL] [Abstract][Full Text] [Related]
19. Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2. Johanns M; Lemoine P; Janssens V; Grieco G; Moestrup SK; Nielsen R; Christensen EI; Courtoy PJ; Emonard H; Marbaix E; Henriet P Sci Rep; 2017 Jun; 7(1):4328. PubMed ID: 28659595 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis. Yamamoto K; Santamaria S; Botkjaer KA; Dudhia J; Troeberg L; Itoh Y; Murphy G; Nagase H Arthritis Rheumatol; 2017 Jun; 69(6):1246-1256. PubMed ID: 28235248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]